SCHEMBL10739956

SCHEMBL10739956

CC[S+]([O-])c1cccc(-c2nc3nccnc3[nH]2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.42
▸ METAP1 P53582 1/20 0.42
▸ AURKA O14965 2/20 0.39
▸ GSK3B P49841 6/20 0.33
▸ CYP1A2 P05177 3/20 0.33
▸ CYP3A4 P08684 3/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ STAT6 P42226 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10740001 0.90 METAP2 (0.40) METAP2METAP1AURKAGSK3BCYP1A2
SCHEMBL10742547 0.86 METAP2 (0.44) METAP2METAP1AURKAGSK3BCYP1A2
SCHEMBL10741398 0.85 METAP2 (0.40) METAP2METAP1AURKAGSK3BCYP1A2
SCHEMBL10736658 0.84 METAP2 (0.39) METAP2METAP1AURKAGSK3BCYP1A2
SCHEMBL10742732 0.84 METAP2 (0.39) METAP2METAP1AURKAGSK3BCYP1A2
SCHEMBL10736104 0.84 METAP2 (0.42) METAP2METAP1AURKAGSK3BTBK1
SCHEMBL10740682 0.76 PDE2A (0.44) METAP2METAP1AURKAGSK3BCYP1A2
SCHEMBL9635757 0.76 KDM4E (0.42) AURKACYP1A2CYP3A4CYP2C9KDM4E
SCHEMBL10740928 0.75 AURKA (0.52) METAP2METAP1AURKAGSK3BCYP3A4
SCHEMBL10742341 0.74 METAP2 (0.43) METAP2METAP1AURKAGSK3BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 — — EP disclosed
Send feedback